🇺🇸 Gonadotropin Releasing Hormone Antagonists Relugolix in United States

Gonadotropin Releasing Hormone Antagonists Relugolix (Gonadotropin Releasing Hormone Antagonists Relugolix) regulatory status in United States.

Marketing authorisation

FDA

  • Status: approved

Gonadotropin Releasing Hormone Antagonists Relugolix in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is Gonadotropin Releasing Hormone Antagonists Relugolix approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for Gonadotropin Releasing Hormone Antagonists Relugolix in United States?

Oregon Health and Science University is the originator. The local marketing authorisation holder may differ — check the official source linked above.